FDA to review Amgen’s new kidney disease dug
Thousand Oaks-based biotech giant Amgen announced on Nov. 6 that the Food and Drug Administration will review a new treatment for patients with chronic kidney disease. The new drug, Etelcalcetide, works by suppressing the secretion of a parathyroid hormone. The drug is administered intravenously three times per week at the end of a dialysis session. Read More →
Read More →Port Hueneme’s Stellar Biotechnologies trading on Nasdaq
Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →
Read More →Mindbody Revenues up, raises guidance slightly.
MindBody, the newly public wellness software service company based in San Luis Obispo, said Nov. 4 that revenue jumped 48 percent to $26.1 million for the third quarter as its loss narrowed compared to a year earlier. The company, which sells products and merchant processing to yoga and fitness centers worldwide, reported a loss of Read More →
Read More →Pacifica Hotels buys El Colibri Boutique Hotel & Spa in Cambria
Pacifica Hotels purchased El Colibri Boutique Hotel & Spa in Cambria for an undisclosed price, the company announced on Oct. 30. The deal marks Pacifica’s fifth property in Cambria. The Irvine-based hotel management company already owns the FogCatcher Inn, Pelican Inn & Suites, Cambria Landing Inn & Suites, and Fireside Inn on Moonstone Beach. The Read More →
Read More →Heritage Oaks Bancorp increases third quarter earnings
Paso Robles-based Heritage Oaks Bancorp reported $4 million in net income, or 12 cents per share, for the third quarter of 2015. That was up from $3.4 million, or 10 cents per share, recorded in the third quarter of last year. Loans grew 4.8 percent, or $55.2 million, to $1.21 billion in the third quarter Read More →
Read More →Teledyne sales dropped in third quarter
Sales slumped once again for Teledyne Technologies in the third quarter. The Thousand Oaks-based industrial conglomerate said it saw sales decline for the third straight quarter when it released third quarter earnings on Oct. 29. Sales fell 7.6 percent from $601.1 million during the third quarter of 2014 to $555.4 million this year. Because of Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
